not tagged
miltenyi Biomedicine
['dlbcl', 'thanks', 'miltenyi', 'biotec,(-biotech)']
 thanks matt for presenting these data! excited to see interim phase ii results maturing after first starting to work with this product in 2017. hopefully dual targeting can improve outcomes for r/r dlbcl!